Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Acta Ophthalmologica|May 31, 2017
Two-year functional and anatomical results after converting treatment resistant eyes with exudative age-related macular degeneration to aflibercept in accordance with a treat and extend protocolØystein Kalsnes Jørstad, Rowan Thomas Faber, Morten Carstens Moe
Acta Ophthalmologica|February 27, 2021
Switching to aflibercept versus continuing bevacizumab for treatment-resistant neovascular age-related macular degeneration: a one-year comparative observational studyYngvil Solheim Husum, Morten Carstens Moe, Ragnheiður Bragadóttir, et al.
Biomedicines|July 29, 2023
Wnt/β-Catenin Signaling Activation Induces Differentiation in Human Limbal Epithelial Stem Cells Cultured Ex VivoJovana Bisevac, Kirankumar Katta, Goran Petrovski, et al.
International Journal of Retina and Vitreous|October 10, 2024
A proof-of-concept study of a prototype needle that mitigates intraocular pressure rise following intravitreal injectionAlexander Sverstad, Olav Kristianslund, Goran Petrovski, et al.
BMJ Open Ophthalmology|November 2, 2019
Patient-reported outcome measures in the management of neovascular age-related macular degeneration: a 1-year prospective studyElma Jelin, Torbjørn Wisløff, Øystein Kalsnes Jørstad, et al.
Ocular Immunology and Inflammation|October 7, 2020
Does Pharmaceutical Compounding of Vascular Endothelial Growth Factor Inhibitors for Intravitreal Use Alter the Risk of Post-injection Endophthalmitis?Kathrine Blom, Ragnheiður Bragadóttir, Magne Sand Sivertsen, et al.
Cells|March 11, 2023
A Novel Technique of Amniotic Membrane Preparation Mimicking Limbal Epithelial Crypts Enhances the Number of Progenitor Cells upon ExpansionJovana Bisevac, Morten Carstens Moe, Liv Drolsum, et al.
Acta Ophthalmologica|July 3, 2019
Thirteen years of intravitreal anti-vascular endothelial growth factor therapy: the promises and burdens of a paradigm shift told from the perspective of the largest retina service in NorwayØystein Kalsnes Jørstad, Leif Arthur Steffensen, Ketil Eriksen, et al.
Acta Ophthalmologica|February 1, 2026
Beyond drug price: A comparison of overall costs of anti-vascular endothelial growth factor therapy alternatives for neovascular age-related macular degeneration in NorwayJacopo F T Løkken, Morten Carstens Moe, Erik Magnus Sæther, et al.
BMJ Open Ophthalmology|December 25, 2024
Zoledronic acid as adjuvant therapy in neovascular age-related macular degeneration: a randomised controlled pilot studyYngvil Solheim Husum, Morten Carstens Moe, Morten Wang Fagerland, et al.
Pageof 4